MA50066A - Compositions à usage topique pour le traitement de la leishmaniose cutanée - Google Patents

Compositions à usage topique pour le traitement de la leishmaniose cutanée

Info

Publication number
MA50066A
MA50066A MA050066A MA50066A MA50066A MA 50066 A MA50066 A MA 50066A MA 050066 A MA050066 A MA 050066A MA 50066 A MA50066 A MA 50066A MA 50066 A MA50066 A MA 50066A
Authority
MA
Morocco
Prior art keywords
compositions
treatment
topical use
leishmaniasis
skin
Prior art date
Application number
MA050066A
Other languages
English (en)
Inventor
Christian Auclair
Esther Fellous
Jorge E Kalil-Filho
Pape Patrice Le
Original Assignee
Ac Bioscience Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ac Bioscience Sa filed Critical Ac Bioscience Sa
Publication of MA50066A publication Critical patent/MA50066A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/01Hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dispersion Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA050066A 2017-09-04 2018-09-03 Compositions à usage topique pour le traitement de la leishmaniose cutanée MA50066A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17306143.3A EP3449906A1 (fr) 2017-09-04 2017-09-04 Composition topique à utiliser dans le traitement de la leishmaniose cutanée

Publications (1)

Publication Number Publication Date
MA50066A true MA50066A (fr) 2021-05-26

Family

ID=59955514

Family Applications (1)

Application Number Title Priority Date Filing Date
MA050066A MA50066A (fr) 2017-09-04 2018-09-03 Compositions à usage topique pour le traitement de la leishmaniose cutanée

Country Status (9)

Country Link
US (1) US11351146B2 (fr)
EP (2) EP3449906A1 (fr)
CN (1) CN111148516A (fr)
BR (1) BR112020004337A2 (fr)
CO (1) CO2020003486A2 (fr)
IL (1) IL272999A (fr)
MA (1) MA50066A (fr)
MX (1) MX2020002358A (fr)
WO (1) WO2019043212A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200155503A1 (en) * 2017-08-03 2020-05-21 Bionoox Sa Compositions for use for treating cutaneous leishmaniasis
US20250057748A1 (en) * 2023-08-15 2025-02-20 Debut Biotechnology, Inc. Formulations of dihydrokaempferol

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2835253B1 (fr) * 2002-01-31 2008-02-01 Pape Patrice Le Composes, en particulier de derives urees ou esters de l'acide haloacetamidobenzoique et leur utilisation pour le traitement de maladies parasitaires

Also Published As

Publication number Publication date
EP3449906A1 (fr) 2019-03-06
IL272999A (en) 2020-04-30
CO2020003486A2 (es) 2020-07-31
WO2019043212A8 (fr) 2019-04-25
US11351146B2 (en) 2022-06-07
MX2020002358A (es) 2020-11-09
CN111148516A (zh) 2020-05-12
US20210059979A1 (en) 2021-03-04
EP3678656A1 (fr) 2020-07-15
WO2019043212A1 (fr) 2019-03-07
BR112020004337A2 (pt) 2020-09-08

Similar Documents

Publication Publication Date Title
MA45481A (fr) Utilisation d'exosomes pour le traitement de maladies
MA47719A (fr) Esketamine pour le traitement de la dépression
EP3431105A4 (fr) Composition médicinale pour le traitement du cancer
EP3448875A4 (fr) Compositions pour le traitement de maladies
EP3448987A4 (fr) Compositions pour le traitement de maladies
EP3504187A4 (fr) Utilisation de la pridopidine pour le traitement du déclin fonctionnel
MA45192A (fr) Traitement d'association
EP3013345A4 (fr) Composés pour le traitement d'une amyotrophie spinale
EP3380200A4 (fr) Compositions pour le traitement des cheveux
EP3466447A4 (fr) Composition pharmaceutique à usage externe indiquée pour le traitement d'ulcères cutanées multiples
EP3946357A4 (fr) Formulations topiques pour le traitement de neuropathies périphériques
EP2957282A4 (fr) Composition antiseptique orale pour le traitement de la mucosite buccale
EP3317274A4 (fr) Utilisation de composés de chloroquine et de clémizole pour le traitement d'états pathologiques inflammatoires et cancéreux
EP3380063A4 (fr) Compositions pour le traitement des cheveux
EP3352749A4 (fr) Composés et compositions pour le traitement de troubles oculaires
MA55218A (fr) Eskétamine pour le traitement de la dépression
EP3541379A4 (fr) Compositions pour le traitement de l'hypertension
EP3538219A4 (fr) Compositions topiques destinées au traitement de l'acné
EP3773221A4 (fr) Traitement pour l'hydrocéphalie
MA43825A (fr) Schémas posologiques pour le traitement d'infections fongiques
EP3347032A4 (fr) Traitement de l'ascite
MA51738A (fr) Composés pour le traitement de la douleur
MA49140A (fr) Composés hétéroaromatiques-aniline fusionnés pour le traitement de troubles dermiques
EP3632430A4 (fr) Agent de prévention ou de traitement de l'ataxie spinocérébelleuse
EP3533471A4 (fr) Composition pour le soulagement ou le traitement de la douleur